We use cookies

By continuing to browse ihf.info, you agree to our terms of use , privacy policy and the use of cookies. For more information, please review our cookie policy.


Prohibited List

The Anti-Doping Unit (ADU) of the International Handball Federation informs that World Anti-Doping Agency (WADA) has released the 2018 Prohibited List. This advisory note details some of the major changes, which will come into effect January 1, 2018.

Under Beta-2 agonists (S3), the maximum permitted dosage of formoterol has increased to 54 micrograms over 24 hours, based on the delivered dose of the drug and not the metered dose. The urinary threshold has been increased to 40 nanograms per millilitre. All beta-2 agonists, excluding sub-threshold levels of formoterol, salbutamol and salmeterol when administered by inhalation, are still prohibited and continue to require a medical exemption.

Insulins have been moved from the Peptide Hormones, Growth Factors and Related Substances (S2) section to the Hormone and Metabolic Modulators (S4) section. Metabolic Modulators (S4.5a) is considered a more appropriate category for insulins based on their mechanism of action.

Under Anabolic Agents (S1), etiocholanolone has been added to the S1.b section as an example of a testosterone metabolite.

The IHF would like to remind the handball players and their support personnel that some stimulants, like many drugs, have several alternate names. For example, methylhexaneamine can be listed under a variety of names, including 1,3-dimethylpentylamine, pentylamine, geranamine, floradrene, forthane and DMAA.

For substances that require a medical exemption, athletes subject to doping control should consult the IHF Anti-Doping Unit or their domestic National Anti-Doping Associations to get complete information on the application process.

·       World Anti-Doping Agency Prohibited List web page
(including the 2018 list, summary of changes, and explanatory note)

·       World Anti-Doping Agency Therapeutic Use Exemption web page